title: Addendum: sartan treatment during pregnancy.
authors.affiliation: Department of Medical Genetics, University of British Columbia, Vancouver, Canada. alwans@interchange.ubc.ca
authors.forename: Sura
authors.initials: S
authors.lastname: Alwan
authors.forename: Janine E
authors.initials: JE
authors.lastname: Polifka
authors.forename: Jan M
authors.initials: JM
authors.lastname: Friedman
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005313:Fetal Death / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D011247:Pregnancy; D013723:Teratogens / Q000633:toxicity
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D013723:Teratogens